Skip to main content

Carlos Molina Cateriano

Institutions of which they are part

Head of group
Stroke research
Vall Hebron Institut de Recerca

Carlos Molina Cateriano

Institutions of which they are part

Head of group
Stroke research
Vall Hebron Institut de Recerca

Projects

NexTOLL: A Phase IIb Clinical Trial to evaluate the neuroprotective effect of ApTOLL in stroke patients

IP: Marc Ribó Jacobi
Collaborators: Marta Aurora Rubiera Del Fueyo, Jorge Pagola Pérez Blanca, Carlos Molina Cateriano, Mª Ángeles Muchada López
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 498435
Reference: CPP2022- 009778
Duration: 09/03/2023 - 08/03/2026

Ministerio de Ciencia

Clinical trial to evaluate the administration of ApTOLL in ambulances and the neuroprotective effect in stroke patients. RACETOLL

IP: Marc Ribó Jacobi
Collaborators: Marta Aurora Rubiera Del Fueyo, Carlos Molina Cateriano, Federica Rizzo
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 437334
Reference: CPP2021-008378
Duration: 01/03/2022 - 28/02/2025

Ministerio de Ciencia

HARMONICS. Harmonization and Implementation of High Value Stroke Care

IP: Carlos Molina Cateriano
Collaborators: Maria Baladas Orti, Ester Sanchez Gavilan, Cristina Guirao Martinez, Estefania Montiel, Marina Jimenez Iglesias, Lidia Garcia Guillamón, Judith Cendrero Correa, Federica Rizzo, Marta Aurora Rubiera Del Fueyo, David Rodriguez Luna, Renato Simonetti
Funding agency: EUROPEAN COMMISSION
Funding: 468090
Reference: HARMONICS_EIT-HEALTH-BP2022
Duration: 01/01/2022 - 31/12/2024

NORA-HOME. EFICIENCIA Y SEGURIDAD DE UN MODELO DE MONITORIZACION MULTIMODAL AMBULATORIA EN PACIENTES CON ICTUS MINOR Y AITS.

IP: Mª Ángeles Muchada López
Collaborators: Carlos Molina Cateriano, Sandra Boned Riera, Juega Mariño, Jesus Maria, Alvaro Garcia Tornel Garcia Camba, Marc Rodrigo Gisbert
Funding agency: Instituto de Salud Carlos III
Funding: 123420
Reference: PI22/01928
Duration: 01/01/2023 - 31/12/2025

Related news

The Consortium will create a platform to facilitate a personalised management for stroke patients, enabling a more efficient personalized monitoring and patient follow up.

Funding is key to bringing the neuroprotective drug ApTOLL to market and providing a new therapeutic option for the patients.

The award is a recognition for his significant contribution to the development of research in multiple sclerosis within the Catalan Institute of Health.

Related professionals

Joan Lima Ruiz

Joan Lima Ruiz

Systemic Diseases
Read more
Carlos Piñana Plaza

Carlos Piñana Plaza

Stroke research
Read more
Beatriz Pacín Ruíz

Beatriz Pacín Ruíz

Research technician
Microbiology
Read more
Maria Regina Codas

Maria Regina Codas

Senior researcher
Infectious Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.